AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GENIP PLC

AGM Information Jun 26, 2025

7670_agm-r_2025-06-26_bead7074-0739-4896-a865-11faa46dfe44.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6288O

GenIP PLC

26 June 2025

26 June 2025

GenIP Plc

("GenIP" or the "Company")

Result of AGM

GenIP Plc (AIM: GNIP), a technology business providing Generative Artificial Intelligence (GenAI) solutions to help research organisations and corporations commercialise their innovations, is pleased to announce that at the Company's Annual General Meeting ("AGM") held earlier today all resolutions were duly passed.

The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:

Resolution For % Against % Votes withheld Total votes cast
Ordinary Resolutions
(1)   Approval of the Annual Report and Accounts 13,895,578 99.95 6,685 0.05 104,665 13,902,263
(2)   Re-appoint HW Fisher LLP as auditor of the Company 13,895,578 99.95 6,685 0.05 104,665 13,902,263
(3)   Authorise the Directors to determine the auditor's remuneration 13,895,578 99.95 6,685 0.05 104,665 13,902,263
(4)   Re-elect Lord David Willetts as a director of the Company 13,767,373 99.03 134,890 0.97 104,665 13,902,263
(5)   Re-elect Melissa Cruz as a director of the Company 13,767,373 99.03 134,890 0.97 104,665 13,902,263
(6)   Re-elect Kevin Fitzpatrick as a director of the Company 13,895,578 99.95 6,685 0.05 104,665 13,902,263
(7)   Re-elect Prof. David Gann CBE as a director of the Company 13,767,373 99.03 134,890 0.97 104,665 13,902,263
(8)   To authorise the Directors to allot shares, up to an aggregate nominal amount of £37,224.61 13,759,681 99.03 134,890 0.97 112,357 13,894,571
Special Resolution
(9)   To authorise the Directors to disapply pre-emption rights when issuing share, up to an aggregate nominal amount of £37,224.61 13,759,681 99.03 134,890 0.97 112,357 13,894,571

Notes:

1.     Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.

2.     Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.     A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.     The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at http://genip.ai/results-presentations/.

As at 26 June 2025, there were 17,517,461 ordinary shares in issue. Shareholders are entitled to one vote per share.

Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

Enquiries:

GenIP Plc

Melissa Cruz, CEO
Via Redchurch Communications
Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish / Asia Szusciak / Andrew Price
Tel:  +44 (0) 20 7628 3396
Novum Securities Limited (Broker) 

Jon Belliss
Tel: +44 (0)20 7399 9425

[email protected]
Redchurch Communications (Financial PR)

John Casey
[email protected]

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

About GenIP

GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services.

GenIP provides two complementary platform-based services:

1.   Invention Evaluator: Provides bespoke research reports that assess the market potential of new technological innovations and discoveries using AI-driven proprietary software; and

2.   Vortechs: which is an executive recruitment platform that through advanced machine learning algorithms and natural language processing technologies assists in matching technology organisations with experienced executives skilled in technology commercialisation.

The Company believes that its integrated GenAI service offerings will help organisations to evaluate and commercialise their technological innovations.

Company Strategy

GenIP's goal is to be a leading Generative AI analytic services company. To achieve this, the Company has established three strategic pillars:

·           Organically grow Invention Evaluator and Vortechs' revenue through institutional and corporate connections as well as increase client pipeline through marketing, advertising and social media spend.

·           Expand the Generative AI service offerings within Invention Evaluator and Vortechs' to reach new customers and improve margins.

·           Bolt-on acquisitions of additional Generative AI services that are helpful to our clients and have demonstrated initial market traction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPKABBPBKDFAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.